Acceptance and Commitment Therapy for Insomnia
ACT-I
1 other identifier
interventional
227
1 country
1
Brief Summary
Insomnia is a frequent complaint and is associated with impairments in physical and psychological health. Although Cognitive-Behavioral Therapy (CBT) demonstrates effective results for insomnia, there are those who do not respond to this type of intervention or present difficulties in adherence. Acceptance and Commitment Therapy (ACT) presents itself as a potentially useful intervention for the treatment of insomnia, for which, instead of focusing on controlling the symptoms, the respective approach focuses on accepting the feelings and thoughts associated, through value-based actions. The aim of this study is to evaluate the effectiveness of ACT for chronic insomnia in adults. Participants will be 150 adults aged between 18 and 59 years, diagnosed with chronic insomnia who will be randomly assigned to the ACT, CBT and wait list (WL) groups. For both groups (ACT and CBT), the intervention will be performed in six group and weekly sessions. Assessments of sleep patterns, insomnia, depression, anxiety, psychological flexibility, acceptance of sleep, beliefs about sleep, personality traits will be performed in the pre-treatment, post-treatment and six-month follow-up. After the intervention is completed, participants will respond to an inventory of compliance and satisfaction. Treatment effects will assessed using the fixed effects of group variables (ACT vs. CBT-I and ACT vs. waitlist) and their interaction with time (pre-test vs. post-test and pretest vs. six-month follow-up). Estimated pairwise contrasts to examine changes across time within groups will be used. Variables will analyzed using generalized mixed models (GMM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2021
CompletedFirst Submitted
Initial submission to the registry
April 13, 2021
CompletedFirst Posted
Study publicly available on registry
April 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2023
CompletedNovember 9, 2023
May 1, 2021
2 years
April 13, 2021
November 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the score of Insomnia Severity Index (ISI)
Change in the total score of Insomnia Severity Index (ISI)
baseline, 7 weeks and 24 weeks after treatment commencement.
Secondary Outcomes (10)
Remission - categorical variable
baseline, 7 weeks and 24 weeks after treatment commencement.
Treatment response - categorical variable
baseline, 7 weeks and 24 weeks after treatment commencement.
Reduction in Sleep Onset Latency (SOL)
baseline, 7 weeks and 24 weeks after treatment commencement.
Reduction in Wake After Sleep Onset (WASO)
baseline, 7 weeks and 24 weeks after treatment commencement.
Increase in Total Sleep Time (TST)
baseline, 7 weeks and 24 weeks after treatment commencement.
- +5 more secondary outcomes
Study Arms (3)
ACT for Insomnia
EXPERIMENTALCBT for Insomnia
ACTIVE COMPARATORWait List
NO INTERVENTIONInterventions
ACT-I treatment group: Participants diagnosed with chronic insomnia will receive group treatment. The six sessions will be aimed at psychoeducation about sleep added to the therapeutic processes of acceptance, mindfulness, availability, values, defusion and commitment, used in ACT.
Active control group CBT-I: Participants diagnosed with chronic insomnia will receive treatment in a group. The six sessions will be aimed at cognitive-behavioral components, such as education and sleep hygiene, stimulus control, sleep restriction and demystification / restructuring of belief beliefs.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of chronic insomnia
You may not qualify if:
- Neurological degenerative disease
- Psychotic disorder
- sleep apnea, restless legs or periodic limb movements during sleep, or a circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome)
- cognitive impairments
- unavailability in attending the sessions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Sao Paulo General Hospital.
São Paulo, 05403903, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
RENATHA RAFIHI-FERREIRA, PHD
University of Sao Paulo General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2021
First Posted
April 30, 2021
Study Start
March 15, 2021
Primary Completion
March 15, 2023
Study Completion
March 15, 2023
Last Updated
November 9, 2023
Record last verified: 2021-05